PRM21 - MODELLING SURVIVAL OF PATIENTS WITH COMPLETELY RESECTED ADVANCED MELANOMA WITH ADJUVANT TREATMENT OF NIVOLUMAB VERSUS OBSERVATION

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2145
https://www.valueinhealthjournal.com/article/S1098-3015(18)35447-0/fulltext
Title : PRM21 - MODELLING SURVIVAL OF PATIENTS WITH COMPLETELY RESECTED ADVANCED MELANOMA WITH ADJUVANT TREATMENT OF NIVOLUMAB VERSUS OBSERVATION
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35447-0&doi=10.1016/j.jval.2018.09.2145
First page :
Section Title :
Open access? : No
Section Order : 1491
Categories :
Tags :
Regions :
ViH Article Tags :